This suggests that direct sensing of intracellular viral products may amplify IFN-responsive and anti-viral gene upregulation, though these pathways are only induced among SARS-CoV-2 RNA+ cells from participants with mild or moderate COVID-19 (Figure 6F). The gene discussed is IFNA1; the disease is COVID-19.